Cargando…
Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity
BACKGROUND: Radiation therapy and chemoradiation therapy play a major role in the definitive management of esophageal cancer. Survival in esophageal cancer patients is still relatively poor, mostly due to high rates of local recurrence and distant metastases. It is hypothesized that dose escalation...
Autores principales: | Ristau, J., Thiel, M., Katayama, S., Schlampp, I., Lang, K., Häfner, M. F., Herfarth, K., Debus, J., Koerber, S. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852221/ https://www.ncbi.nlm.nih.gov/pubmed/33522923 http://dx.doi.org/10.1186/s13014-021-01749-x |
Ejemplares similares
-
Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
por: Krug, David, et al.
Publicado: (2020) -
Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer
por: Liermann, Jakob, et al.
Publicado: (2021) -
Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy
por: Haefner, Matthias F., et al.
Publicado: (2015) -
Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity
por: Haefner, Matthias Felix, et al.
Publicado: (2017) -
Different definitions of esophagus influence esophageal toxicity prediction for esophageal cancer patients administered simultaneous integrated boost versus standard-dose radiation therapy
por: Huang, Bao-tian, et al.
Publicado: (2017)